Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angion Biomedica Corp (NQ: ANGN )

0.4995 -0.0205 (-3.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,372
Open 0.4995
Bid (Size) 0.4995 (1)
Ask (Size) 0.5300 (6)
Prev. Close 0.5200
Today's Range 0.4995 - 0.5204
52wk Range 0.5000 - 2.500
Shares Outstanding 29,798,399
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sumo Logic (Nasdaq – SUMO), Angion Biomedica Corp (Nasdaq - ANGN), TravelCenters of America Inc. (Nasdaq - TA), IAA, Inc. (NYSE - IAA)
From Brodsky & Smith LLC
Via Globe NewsWire

Performance

YTD
-42.71%
-42.71%
1 Month
-22.62%
-22.62%
3 Month
-38.49%
-38.49%
6 Month
-52.43%
-52.43%
1 Year
-76.88%
-76.88%

More News

Read More
ANGION BIOMEDICA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Angion Biomedica Corp - ANGN
From Kahn Swick & Foti, LLC
Via Business Wire
HC Wainwright Downgrades Angion Biomedica
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
Via Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
Via Benzinga
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Angion Biomedica Corp (Nasdaq - ANGN)
From Brodsky & Smith LLC
Via Globe NewsWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Elicio Therapeutics and Angion Enter into Definitive Merger Agreement
From Angion Biomedica Corp.
Via Globe NewsWire
Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
From Angion Biomedica Corp.
Via Globe NewsWire
Angion Biomedica's Return On Capital Employed Overview
Via Benzinga
Recap: Angion Biomedica Q2 Earnings
Via Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Via Benzinga
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
From Angion Biomedica Corp.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Down 100 Points; Angion Biomedica Shares Plummet
Via Benzinga
Dow Drops 250 Points; Rapid Micro Biosystems Shares Spike Higher
Via Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
Via Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.